EUCTR2010-019581-82-CZ进行中（未招募）不适用
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients with Type 2 Diabetes Mellitus - GBD
Eli Lilly & Company0 个研究点目标入组 693 人开始时间: 2010年6月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 693
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Men and nonpregnant women aged =18 years with type 2 diabetes, treated with 1 or more oral antidiabetic medicines, an HbA1c =7.0% and =9.5%, a BP >90/60 mmHg and <140/90 mmHg; if hypertensive on 3 or less antihypertensive medications (same regimen for at least 1 month), and a stable weight with a BMI =23 kg/m2, will be enrolled.
- •See protocol for full details of inclusion criteria.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 693
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •See protocol for full details of exclusion criteria.
研究者
相似试验
进行中（未招募）
不适用
The Effect of LY2189265 on Blood Pressure and Heart Rate, as Assessed by Ambulatory Blood Pressure Monitoring, in Patients with Type 2 Diabetes Mellitus - GBDMedDRA version: 12.1Level: LLTClassification code 10012601Term: Diabetes mellitusType 2 Diabetes MellitusEUCTR2010-019581-82-DEEli Lilly & Company693
已完成
2 期
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesCTRI/2010/091/001444Eli Lilly683
进行中（未招募）
不适用
To know how LY2189265 affects (that is, increases, decreases or no change) blood pressure and heart rate in patients with type 2 diabetes mellitusType 2 Diabetes MellitusEUCTR2010-019581-82-DKEli Lilly & Company693
已完成
2 期
A Study of the Effect of LY2189265 on Blood Pressure and Heart Rate in Type 2 DiabetesDiabetes Mellitus, Type 2NCT01149421Eli Lilly and Company755
已完成
2 期
A Study of LY2409021 on Blood Pressure and Pulse Rate in Participants With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT02091362Eli Lilly and Company270